Article info
PDFTherapeutics
Randomised controlled trial
Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine–pyrimethamine, but safety and tolerability issues need consideration
- Correspondence to Rose McGready
Mahidol Oxford University Tropical Medicine Research Programme, Shoklo Malaria Research Unit, PO Box 46, 63110 Mae Sot, Tak, Thailand; rose{at}shoklo-unit.com
Citation
Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine–pyrimethamine, but safety and tolerability issues need consideration
Publication history
- First published June 3, 2010.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions